{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T06:57:11Z","timestamp":1793429831887,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ophtha.2017.05.037","type":"journal-article","created":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T21:31:02Z","timestamp":1500067862000},"page":"127-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Treatments for Ocular Adnexal Lymphoma"],"prefix":"10.1016","volume":"125","author":[{"given":"Michael T.","family":"Yen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurij R.","family":"Bilyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Wladis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise A.","family":"Mawn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2017.05.037_bib1","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0360-3016(03)00767-3","article-title":"Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes","volume":"57","author":"Fung","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ophtha.2017.05.037_bib2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/028418601750288217","article-title":"Non-Hodgkin's lymphoma of the ocular adnexa","volume":"40","author":"Sasai","year":"2001","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ophtha.2017.05.037_bib3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2141.2010.08429.x","article-title":"Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): single institution experience in a large cohort of patients","volume":"152","author":"Bayraktar","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ophtha.2017.05.037_bib4","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/1097-0142(197201)29:1<252::AID-CNCR2820290138>3.0.CO;2-#","article-title":"Occurrence and prognosis of extranodal lymphomas","volume":"29","author":"Freeman","year":"1972","journal-title":"Cancer"},{"key":"10.1016\/j.ophtha.2017.05.037_bib5","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/ICU.0b013e3282be8fbb","article-title":"Lymphoproliferative disease of the orbit","volume":"18","author":"Bernardini","year":"2007","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.037_bib6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0161-6420(98)92107-8","article-title":"Malignant tumors of the orbit. Analysis of the Florida Cancer Registry","volume":"105","author":"Margo","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.05.037_bib7","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jamaophthalmol.2014.376","article-title":"Ocular adnexal follicular lymphoma: a multicenter international study","volume":"132","author":"Rasmussen","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.037_bib8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/PAP.0b013e3181e4abdb","article-title":"Ocular adnexal lymphomas: a review","volume":"17","author":"McKelvie","year":"2010","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.ophtha.2017.05.037_bib9","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/S0161-6420(95)30764-6","article-title":"Ocular adnexal lymphoma. A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type","volume":"102","author":"White","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.05.037_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ajh.10332","article-title":"Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone B-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients","volume":"73","author":"Cho","year":"2003","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ophtha.2017.05.037_bib11","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/01.pas.0000213350.49767.46","article-title":"Lymphoma of the ocular adnexa: a study of 353 cases","volume":"31","author":"Ferry","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ophtha.2017.05.037_bib12","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1200\/JCO.2011.41.4466","article-title":"Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial","volume":"30","author":"Ferreri","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ophtha.2017.05.037_bib13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1182\/blood-2005-06-2332","article-title":"Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci","volume":"107","author":"Rosado","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ophtha.2017.05.037_bib14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/01.IOP.0000159173.42243.AD","article-title":"Lymphoproliferative disease of the ocular adnexa: a clinical and pathologic study with statistical analysis of 69 patients","volume":"21","author":"Sullivan","year":"2005","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.ophtha.2017.05.037_bib15","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/sj.eye.6702382","article-title":"Imaging features of ocular adnexal lymphoproliferative disease","volume":"20","author":"Sullivan","year":"2006","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2017.05.037_bib16","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ajo.2005.02.044","article-title":"Combined positron emission tomography\/computed tomography imaging of orbital lymphoma","volume":"140","author":"Chan-Kai","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.037_bib18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000093804","article-title":"Addition of a short course of chemotherapy did not improve outcome in patients with localized marginal B-cell lymphoma of the orbit","volume":"70","author":"Aviles","year":"2006","journal-title":"Oncology"},{"key":"10.1016\/j.ophtha.2017.05.037_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00066-007-1627-z","article-title":"Radiotherapy for orbital lymphoma: outcome and late effects","volume":"183","author":"Bischof","year":"2007","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ophtha.2017.05.037_bib20","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1748-717X-4-60","article-title":"Radiation therapy in primary orbital lymphoma: a single institution retrospective analysis","volume":"4","author":"De Cicco","year":"2009","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ophtha.2017.05.037_bib21","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1002\/cncr.25226","article-title":"Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy","volume":"116","author":"Goda","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ophtha.2017.05.037_bib22","doi-asserted-by":"crossref","first-page":"e659","DOI":"10.1016\/j.ijrobp.2011.03.050","article-title":"Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: efficacy and toxicity","volume":"81","author":"Goda","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ophtha.2017.05.037_bib23","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00277-014-2240-8","article-title":"Long-term outcomes of first-line treatment with doxycycline in patients with previously untreated ocular adnexal marginal zone B cell lymphoma","volume":"94","author":"Han","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ophtha.2017.05.037_bib24","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ijrobp.2013.11.235","article-title":"Localized ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiation therapy: a long-term outcome in 86 patients with 104 treated eyes","volume":"88","author":"Harada","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ophtha.2017.05.037_bib25","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.ijrobp.2011.04.052","article-title":"Long-term outcome and patterns of failure in primary ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy","volume":"82","author":"Hashimoto","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ophtha.2017.05.037_bib26","doi-asserted-by":"crossref","first-page":"e104004","DOI":"10.1371\/journal.pone.0104004","article-title":"Clinical features, treatment and outcome of mucosa-associated lymphoid tissue (MALT) lymphoma of the ocular adnexa: single center experience of 60 patients","volume":"9","author":"Kiesewetter","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ophtha.2017.05.037_bib27","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s00066-016-0962-3","article-title":"Radiotherapy of indolent orbital lymphomas: two radiation concepts","volume":"192","author":"Konig","year":"2016","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ophtha.2017.05.037_bib28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4103\/0301-4738.81993","article-title":"Extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue type of the ocular adnexa: retrospective single institution review of 95 patients","volume":"59","author":"Lim","year":"2011","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.037_bib29","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0360-3016(02)04159-7","article-title":"Outcome and prognostic factors in orbital lymphoma: a Rare Cancer Network study on 90 consecutive patients treated with radiotherapy","volume":"55","author":"Martinet","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ophtha.2017.05.037_bib30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jamaophthalmol.2014.4644","article-title":"Ocular adnexal diffuse large B-cell lymphoma: a multicenter international study","volume":"133","author":"Munch-Petersen","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.037_bib31","first-page":"3591","article-title":"Treatment outcome of radiotherapy for localized primary ocular adnexal MALT lymphoma\u2014prognostic effect of the AJCC tumor-node-metastasis clinical staging system","volume":"35","author":"Ohga","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ophtha.2017.05.037_bib32","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3109\/10428194.2014.979415","article-title":"Long-term outcomes and patterns of failure in orbital lymphoma treated with primary radiotherapy","volume":"56","author":"Parikh","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ophtha.2017.05.037_bib33","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/IOP.0b013e31821cc4bb","article-title":"Primary, unilateral ocular adnexal lymphoma: disease progression and long-term survival","volume":"27","author":"Rootman","year":"2011","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.ophtha.2017.05.037_bib34","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijrobp.2009.04.018","article-title":"Primary radiation therapy in patients with localized orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)","volume":"77","author":"Son","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ophtha.2017.05.037_bib35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0167-8140(00)00328-5","article-title":"Orbital lymphoma: radiotherapy outcome and complications","volume":"59","author":"Stafford","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ophtha.2017.05.037_bib36","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijrobp.2005.11.035","article-title":"Orbital marginal zone B-cell lymphoma of MALT: radiotherapy results and clinical behavior","volume":"65","author":"Suh","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ophtha.2017.05.037_bib37","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/cncr.11539","article-title":"Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients","volume":"98","author":"Uno","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ophtha.2017.05.037_bib38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.clon.2014.10.002","article-title":"Outcomes of primary lymphoma of the ocular adnexa (orbital lymphoma) treated with radiotherapy","volume":"27","author":"Woolf","year":"2015","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ophtha.2017.05.037_bib39","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/IOP.0b013e318030b058","article-title":"Prognosis for patients in a Korean population with ocular adnexal lymphoproliferative lesions","volume":"23","author":"Yoon","year":"2007","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.ophtha.2017.05.037_bib40","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/jnci\/djh102","article-title":"Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas","volume":"96","author":"Ferreri","year":"2004","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ophtha.2017.05.037_bib41","first-page":"213","article-title":"Gastric MALT lymphoma and Helicobacter pylori","volume":"30","author":"Spencer","year":"1997","journal-title":"Cancer Surv"},{"key":"10.1016\/j.ophtha.2017.05.037_bib42","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/01.pas.0000249445.28713.88","article-title":"Extranodal marginal zone B-cell lymphomas of the ocular adnexa: multiparameter analysis of 34 cases including interphase molecular cytogenetics and PCR for Chlamydia psittaci","volume":"31","author":"Ruiz","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ophtha.2017.05.037_bib43","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1200\/JCO.2008.21.3017","article-title":"Phase I study of the humanized anti-CD40 monoclonal antibody dacetuzumab in refractory or recurrent non-Hodgkin's lymphoma","volume":"27","author":"Advani","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ophtha.2017.05.037_bib44","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3109\/10428194.2010.534519","article-title":"90Y-ibritumomab tiuxetan (Zevalin) in heavily pretreated patients with mucosa associated lymphoid tissue lymphoma","volume":"52","author":"Hoffmann","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ophtha.2017.05.037_bib45","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3109\/09273948.2012.689071","article-title":"Interleukin-2 receptor targeted therapy of ocular disease of HTLV-1-associated adult T-cell leukemia","volume":"20","author":"Larson","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ophtha.2017.05.037_bib46","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.leukres.2011.01.030","article-title":"Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: safety and efficacy evaluation","volume":"35","author":"Laurenti","year":"2011","journal-title":"Leuk Res"},{"key":"10.1016\/j.ophtha.2017.05.037_bib47","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.ijrobp.2013.04.035","article-title":"Low-dose radiation therapy (2 Gy x 2) in the treatment of orbital lymphoma","volume":"86","author":"Fasola","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642017317189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642017317189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:08:12Z","timestamp":1758982092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642017317189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0161642017317189"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2017.05.037","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727815195.793542251","asserted-by":"object"}]},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatments for Ocular Adnexal Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2017.05.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}